Triparanol
Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts.
Also Known As:
MER-29; Metasqualene; MER 29; MER29; Benzeneethanol, 4-chloro-alpha-(4-(2-(diethylamino)ethoxy)phenyl)-alpha-(4-methylphenyl)-
Networked: 69
relevant articles (0 outcomes,
3 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Alman, Benjamin A:
2 articles
(01/2006 - 06/2005)
|
2. | Hopyan, Sevan:
2 articles
(01/2006 - 06/2005)
|
3. | Nadesan, Puviindran:
2 articles
(01/2006 - 06/2005)
|
4. | Alzoubi, Kousi:
1 article
(08/2015)
|
5. | Lang, Florian:
1 article
(08/2015)
|
6. | Manna, Caterina:
1 article
(08/2015)
|
7. | Officioso, Arbace:
1 article
(08/2015)
|
8. | Bi, Xinyu:
1 article
(08/2012)
|
9. | Han, Xingpeng:
1 article
(08/2012)
|
10. | He, Miao:
1 article
(08/2012)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures